1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19
on Global Clinical Biomarkers Market
5. Voice of Customer
6.
Global Clinical Biomarkers Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Product (Efficacy Biomarkers, Safety Biomarkers,
Validation Biomarkers)
6.2.2. By Services (Genomic Biomarker Service, Tissue Biomarker
Service, Cell Service,
Proteomics Service)
6.2.3. By Technology (Next Generation Sequencing, Polymerase
Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay,
Others)
6.2.4. By Clinical Area (Cancer Biomarker, Cardiac Biomarker,
Neurological Biomarker, Infectious Disease Biomarker, Others)
6.2.5. By Application (Translational Research v/s Clinical
Diagnostics)
6.2.6. By End User (Biotechnology & Pharmaceutical
Companies, Diagnostic Centers, Academic & Research Institutions, Others)
6.2.7. By Region
6.2.8. By Company (2021)
6.3. Market Map
7.
North America Clinical Biomarkers Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Product
7.2.2. By Services
7.2.3. By Technology
7.2.4. By Clinical Area
7.2.5. By Application
7.2.6. By End User
7.2.7. By Country
7.3. North America:
Country Analysis
7.3.1. United States Clinical
Biomarkers Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Services
7.3.1.2.3.
By Technology
7.3.1.2.4.
By Clinical Area
7.3.1.2.5.
By Application
7.3.1.2.6.
By End User
7.3.2. Canada Clinical
Biomarkers Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Services
7.3.2.2.3.
By Technology
7.3.2.2.4.
By Clinical Area
7.3.2.2.5.
By Application
7.3.2.2.6.
By End User
7.3.3. Mexico Clinical
Biomarkers Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Services
7.3.3.2.3.
By Technology
7.3.3.2.4.
By Clinical Area
7.3.3.2.5.
By Application
7.3.3.2.6.
By End User
8.
Europe Clinical Biomarkers Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Product
8.2.2. By Services
8.2.3. By Technology
8.2.4. By Clinical Area
8.2.5. By Application
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country
Analysis
8.3.1. France Clinical
Biomarkers Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Services
8.3.1.2.3.
By Technology
8.3.1.2.4.
By Clinical Area
8.3.1.2.5.
By Application
8.3.1.2.6.
By End User
8.3.2. Germany Clinical
Biomarkers Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Services
8.3.2.2.3.
By Technology
8.3.2.2.4.
By Clinical Area
8.3.2.2.5.
By Application
8.3.2.2.6.
By End User
8.3.3. United Kingdom Clinical
Biomarkers Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Services
8.3.3.2.3.
By Technology
8.3.3.2.4.
By Clinical Area
8.3.3.2.5.
By Application
8.3.3.2.6.
By End User
8.3.4. Italy Clinical
Biomarkers Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Services
8.3.4.2.3.
By Technology
8.3.4.2.4.
By Clinical Area
8.3.4.2.5.
By Application
8.3.4.2.6.
By End User
8.3.5. Spain Clinical
Biomarkers Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Services
8.3.5.2.3.
By Technology
8.3.5.2.4.
By Clinical Area
8.3.5.2.5.
By Application
8.3.5.2.6.
By End User
9.
Asia-Pacific Clinical Biomarkers Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Product
9.2.2. By Services
9.2.3. By Technology
9.2.4. By Clinical Area
9.2.5. By Application
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Clinical
Biomarkers Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Services
9.3.1.2.3.
By Technology
9.3.1.2.4.
By Clinical Area
9.3.1.2.5.
By Application
9.3.1.2.6.
By End User
9.3.2. India Clinical
Biomarkers Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Services
9.3.2.2.3.
By Technology
9.3.2.2.4.
By Clinical Area
9.3.2.2.5.
By Application
9.3.2.2.6.
By End User
9.3.3. Japan Clinical
Biomarkers Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Services
9.3.3.2.3.
By Technology
9.3.3.2.4.
By Clinical Area
9.3.3.2.5.
By Application
9.3.3.2.6.
By End User
9.3.4. South Korea Clinical
Biomarkers Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product
9.3.4.2.2.
By Services
9.3.4.2.3.
By Technology
9.3.4.2.4.
By Clinical Area
9.3.4.2.5.
By Application
9.3.4.2.6.
By End User
9.3.5. Australia Clinical
Biomarkers Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Product
9.3.5.2.2.
By Services
9.3.5.2.3.
By Technology
9.3.5.2.4.
By Clinical Area
9.3.5.2.5.
By Application
9.3.5.2.6.
By End User
10.
South America Clinical Biomarkers Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product
10.2.2. By Services
10.2.3. By Technology
10.2.4. By Clinical Area
10.2.5. By Application
10.2.6. By End User
10.2.7. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Clinical
Biomarkers Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Services
10.3.1.2.3.
By Technology
10.3.1.2.4.
By Clinical Area
10.3.1.2.5.
By Application
10.3.1.2.6.
By End User
10.3.2. Argentina Clinical
Biomarkers Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Services
10.3.2.2.3.
By Technology
10.3.2.2.4.
By Clinical Area
10.3.2.2.5.
By Application
10.3.2.2.6.
By End User
10.3.3. Colombia Clinical
Biomarkers Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Services
10.3.3.2.3.
By Technology
10.3.3.2.4.
By Clinical Area
10.3.3.2.5.
By Application
10.3.3.2.6.
By End User
11.
Middle East and Africa Clinical Biomarkers Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Product
11.2.2. By Services
11.2.3. By Technology
11.2.4. By Clinical Area
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Clinical
Biomarkers Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Services
11.3.1.2.3.
By Technology
11.3.1.2.4.
By Clinical Area
11.3.1.2.5.
By Application
11.3.1.2.6.
By End User
11.3.2. Saudi Arabia Clinical
Biomarkers Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Services
11.3.2.2.3.
By Technology
11.3.2.2.4.
By Clinical Area
11.3.2.2.5.
By Application
11.3.2.2.6.
By End User
11.3.3. UAE Clinical
Biomarkers Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Services
11.3.3.2.3.
By Technology
11.3.3.2.4.
By Clinical Area
11.3.3.2.5.
By Application
11.3.3.2.6.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape (Inclusive of SWOT Analysis)
14.1.
Agilent Technologies, Inc.
14.2.
Illumina, Inc.
14.3.
F. Hoffmann-La Roche AG
14.4.
QIAGEN NV
14.5.
PerkinElmer, Inc
14.6.
Thermo Fischer Scientific, Inc.
14.7.
Bio-Rad Laboratories, Inc.
14.8.
NeoGenomics Laboratories, Inc.
14.9.
Charles River Laboratories International, Inc.
14.10.
Quest Diagnostics, Inc.
14.11.
Abbott Laboratories, Inc.
14.12.
Enzo Biochem Inc.
14.13.
Myriad Genetics, Inc.
14.14.
CENTOGENE N.V.
14.15.
bioMérieux S.A.
15. Strategic Recommendations